Hedge Fund - OrbiMed Advisors
Vertex Pharmaceuticals Inc / Ma (VRTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $77,522,718 | 1.85% | 159,900 | $466.00 |
| 2 | 2024 - Q4 (2024-12-31) | $60,807,700 | 1.25% | 151,000 | $463.53 |
| 3 | 2024 - Q3 (2024-09-30) | $70,227,080 | 1.27% | 151,000 | $480.37 |
| 4 | 2024 - Q2 (2024-06-30) | $70,776,720 | 1.39% | 151,000 | $434.05 |
| 5 | 2024 - Q1 (2024-03-31) | $51,289,827 | 0.93% | 122,700 | $422.74 |
| 6 | 2023 - Q4 (2023-12-31) | $71,287,128 | 1.42% | 175,200 | $369.42 |
| 7 | 2023 - Q3 (2023-09-30) | $57,516,196 | 1.22% | 165,400 | $349.73 |
| 8 | 2023 - Q2 (2023-06-30) | $58,205,914 | 1.05% | 165,400 | $336.94 |
| 9 | 2023 - Q1 (2023-03-31) | $55,956,432 | 1.09% | 177,600 | $299.93 |
| 10 | 2022 - Q4 (2022-12-31) | $78,403,770 | 1.49% | 271,500 | $304.77 |
| 11 | 2022 - Q3 (2022-09-30) | $108,056,000 | 2% | 373,200 | $287.72 |
| 12 | 2022 - Q2 (2022-06-30) | $109,109,000 | 1.97% | 387,200 | $267.66 |
| 13 | 2022 - Q1 (2022-03-31) | $104,440,000 | 1.69% | 400,200 | $237.33 |
| 14 | 2021 - Q4 (2021-12-31) | $144,519,000 | 1.85% | 658,100 | $194.45 |
| 15 | 2021 - Q3 (2021-09-30) | $159,152,000 | 1.74% | 877,400 | $195.24 |
| 16 | 2021 - Q2 (2021-06-30) | $214,817,000 | 2.17% | 1,065,400 | $209.17 |
| 17 | 2021 - Q1 (2021-03-31) | $244,094,000 | 2.28% | 1,135,900 | $219.65 |
| 18 | 2020 - Q4 (2020-12-31) | $197,131,000 | 1.72% | 834,100 | $229.44 |
| 19 | 2020 - Q3 (2020-09-30) | $181,259,000 | 2.27% | 666,100 | $275.88 |
| 20 | 2020 - Q2 (2020-06-30) | $193,375,000 | 2.72% | 666,100 | $271.12 |
| 21 | 2020 - Q1 (2020-03-31) | $175,464,000 | 2.94% | 737,400 | $229.39 |
| 22 | 2019 - Q4 (2019-12-31) | $171,460,000 | 2.44% | 783,100 | $202.38 |
| 23 | 2019 - Q3 (2019-09-30) | $143,397,000 | 2.72% | 846,400 | $176.91 |
| 24 | 2019 - Q2 (2019-06-30) | $178,484,000 | 2.76% | 973,300 | $174.82 |
| 25 | 2019 - Q1 (2019-03-31) | $175,727,000 | 2.72% | 955,300 | $184.70 |
| 26 | 2018 - Q4 (2018-12-31) | $187,783,000 | 3.47% | 1,133,200 | $173.27 |
| 27 | 2018 - Q3 (2018-09-30) | $308,480,000 | 3.71% | 1,600,500 | $178.07 |
| 28 | 2018 - Q2 (2018-06-30) | $304,670,000 | 3.63% | 1,792,600 | $155.01 |
| 29 | 2018 - Q1 (2018-03-31) | $302,263,000 | 3.74% | 1,854,600 | $163.34 |
| 30 | 2017 - Q4 (2017-12-31) | $260,951,000 | 3.3% | 1,741,300 | $148.07 |
| 31 | 2017 - Q3 (2017-09-30) | $315,377,000 | 3.01% | 2,074,302 | $150.51 |
| 32 | 2017 - Q2 (2017-06-30) | $261,155,000 | 2.73% | 2,026,502 | $120.38 |
| 33 | 2017 - Q1 (2017-03-31) | $237,202,000 | 2.68% | 2,169,200 | $88.04 |
| 34 | 2016 - Q4 (2016-12-31) | $159,083,000 | 2.02% | 2,159,400 | $81.37 |
| 35 | 2016 - Q3 (2016-09-30) | $140,583,000 | 1.6% | 1,612,000 | $94.50 |
| 36 | 2016 - Q2 (2016-06-30) | $188,324,000 | 1.96% | 2,189,300 | $86.41 |
| 37 | 2016 - Q1 (2016-03-31) | $148,599,000 | 1.56% | 1,869,400 | $90.45 |
| 38 | 2015 - Q4 (2015-12-31) | $84,684,000 | 0.76% | 673,000 | $120.72 |
| 39 | 2015 - Q3 (2015-09-30) | $11,976,000 | 0.12% | 115,000 | $128.47 |
| 40 | 2015 - Q2 (2015-06-30) | $14,200,000 | 0.11% | 115,000 | $125.98 |
| 41 | 2015 - Q1 (2015-03-31) | $15,926,000 | 0.13% | 135,000 | $119.81 |
| 42 | 2014 - Q4 (2014-12-31) | $205,667,000 | 1.96% | 1,731,200 | $112.63 |
| 43 | 2014 - Q3 (2014-09-30) | $151,619,000 | 1.58% | 1,350,000 | $95.21 |
| 44 | 2014 - Q2 (2014-06-30) | $49,991,000 | 0.58% | 528,000 | $70.12 |
| 45 | 2014 - Q1 (2014-03-31) | $11,315,000 | 0.13% | 160,000 | $79.20 |
| 46 | 2013 - Q4 (2013-12-31) | $18,947,000 | 0.27% | 255,000 | $69.64 |
| 47 | 2013 - Q3 (2013-09-30) | $25,627,000 | 0.45% | 338,000 | $79.57 |
| 48 | 2013 - Q2 (2013-06-30) | $17,853,000 | 0.37% | 223,000 | $73.64 |
| 49 | 2013 - Q1 (2013-03-31) | $8,355,000 | 0.19% | 152,000 | $48.01 |
| 50 | 2012 - Q4 (2012-12-31) | $3,645,000 | 0.11% | 87,000 | $46.18 |
| 51 | 2012 - Q3 (2012-09-30) | $0 | 0% | 0 | $53.75 |
| 52 | 2012 - Q1 (2012-03-31) | $4,880,000 | 0.14% | 119,000 | $38.22 |
| 53 | 2011 - Q1 (2011-03-31) | $0 | 0% | 0 | $42.02 |
| 54 | 2010 - Q4 (2010-12-31) | $58,059,000 | 2.09% | 1,657,400 | $35.01 |
The displayed share prices are average quarterly stock market prices.